Lilly(US:LLY) The Motley Fool·2025-05-11 10:05Core Viewpoint - Companies like Eli Lilly and Visa are positioned to potentially reach a market cap of $1 trillion by 2030, making them attractive long-term investment opportunities due to their growth prospects and market positions [1]. Eli Lilly - Eli Lilly has a current market cap of just under $737 billion and needs a compound annual growth rate (CAGR) of 6.3% to reach $1 trillion by 2030, which is below the market's historical performance [3][4]. - The company faces challenges such as market-wide issues and high valuation metrics, with a forward price-to-earnings (P/E) ratio of 35.4, significantly higher than the healthcare sector average of 16 [3][4]. - Eli Lilly's innovative pipeline includes investigational weight management medicines and a promising gene therapy for deafness, positioning it well in the growing weight loss market [5][7]. - The company has a strong dividend growth history, which can enhance returns for long-term investors [7]. Visa - Visa's market cap is just under $679 billion, requiring a CAGR of 8.1% to achieve a $1 trillion valuation by 2030, which is manageable within equity market standards [8]. - The company benefits from inflation as its fees are transaction-based, potentially increasing revenue during economic fluctuations [8][9]. - Visa has demonstrated resilience during economic downturns, maintaining strong performance despite challenges like the pandemic [9][10]. - The company enjoys a dominant position in the payment technology sector with a strong network effect, making it difficult for competitors to disrupt its market [10]. - Visa has significant growth prospects due to the ongoing shift from cash to credit and debit transactions, as well as the expansion of e-commerce [11].